Xtant Medical Holdings (XMS) Stock Statistics & Valuation Metrics
Total Valuation
Xtant Medical Holdings has a market cap or net worth of EUR 35.20M. The enterprise value is EUR 74.84M.
- Market Cap
- EUR 35.20M
- Enterprise Value
- EUR 74.84M
Share Statistics
Xtant Medical Holdings has 140,287,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 140,287,960
- Owned by Insiders
- 12.05%
- Owned by Institutions
- 3.65%
Financial Efficiency
Xtant Medical Holdings’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.49%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 6.49%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 886.93K
- Profits Per Employee
- 32.93K
- Employee Count
- 151
- Asset Turnover
- 1.42
- Inventory Turnover
- 1.64
Valuation Ratios
The current PE Ratio of Xtant Medical Holdings is -3.40. Xtant Medical Holdings’s PEG ratio is 0.00.
- PE Ratio
- -3.40
- PS Ratio
- 0.36
- PB Ratio
- 0.98
- Price to FCF
- -56.48
- Price to Operating Cash Flow
- 68.95
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Xtant Medical Holdings had revenue of 133.93M and earned 4.97M in profits. Earnings per share was 0.04.
- Revenue
- 133.93M
- Gross Profit
- 84.27M
- Operating Income
- 7.28M
- Pretax Income
- 7.00M
- Net Income
- 4.97M
- EBITDA
- 15.89M
- Earnings Per Share (EPS)
- 0.04
Cash Flow
In the last 12 months, operating cash flow was 570.00K and capital expenditures -1.27M, giving a free cash flow of -696.00K billion.
- Operating Cash Flow
- 570.00K
- Free Cash Flow
- -696.00K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Xtant Medical Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.77%
- Earnings Yield
- -28.34%
Stock Price Statistics
- Beta
- 0.54
- 52-Week Price Change
- -67.27%
- 50-Day Moving Average
- 0.29
- 200-Day Moving Average
- 0.39
- Relative Strength Index (RSI)
- 41.15
- Average Volume (3m)
- 7,833
Important Dates
Xtant Medical Holdings upcoming earnings date is Nov 06, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 06, 2026
- Ex-Dividend Date
- ―
Financial Position
Xtant Medical Holdings as a current ratio of 2.65, with Debt / Equity ratio of 56.36%
- Current Ratio
- 2.65
- Quick Ratio
- 1.63
- Debt to Market Cap
- 0.23
- Net Debt to EBITDA
- 0.73
- Interest Coverage Ratio
- 1.98
Taxes
In the past 12 months, Xtant Medical Holdings has paid 2.03M in taxes.
- Income Tax
- 2.03M
- Effective Tax Rate
- 0.29
Enterprise Valuation
Xtant Medical Holdings EV to EBITDA ratio is -22.60, with an EV/FCF ratio of -79.67.
- EV to Sales
- 0.51
- EV to EBITDA
- -22.60
- EV to Free Cash Flow
- -79.67
- EV to Operating Cash Flow
- 97.28
Balance Sheet
Xtant Medical Holdings has EUR 9.87M in cash and marketable securities with EUR 26.01M in debt, giving a net cash position of -EUR 16.14M billion.
- Cash & Marketable Securities
- EUR 9.87M
- Total Debt
- EUR 26.01M
- Net Cash
- -EUR 16.14M
- Net Cash Per Share
- -EUR 0.12
- Tangible Book Value Per Share
- EUR 0.24
Margins
Gross margin is 59.39%, with operating margin of -9.58%, and net profit margin of -10.17%.
- Gross Margin
- 59.39%
- Operating Margin
- -9.58%
- Pretax Margin
- -8.44%
- Net Profit Margin
- -10.17%
- EBITDA Margin
- -2.24%
- EBIT Margin
- -5.91%
Analyst Forecast
The average price target for Xtant Medical Holdings is EUR 0.92, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 0.92
- Price Target Upside
- 265.93% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- -20.06%
- EPS Growth Forecast
- -111.15%
Scores
- Smart Score
- 6
- AI Score
- ―
